Literature DB >> 17196555

Dopaminergic development of prenatal ventral mesencephalon and striatum in organotypic co-cultures.

Gregory D Lyng1, Abigail Snyder-Keller, Richard F Seegal.   

Abstract

Using organotypic co-cultures of rat embryonic day 14 (E14) ventral mesencephalon (VM) and E21 striatum, we have described the developmental changes in (i) dopamine (DA) neurochemistry; (ii) numbers of DA neurons; and (iii) protein expression of tyrosine hydroxylase (TH), DA transporter (DAT), and glutamic acid decarboxylase (GAD 65/67), over 17 days in vitro (DIV). Co-cultures demonstrated changes in DA development similar to those observed in vivo. The numbers of VM DA neurons remained relatively constant, while levels of VM DA progressively increased through 10 DIV. After 3 DIV, the levels of striatal DA increased substantially, through 10 DIV. Tissue levels of DA metabolites homovanillic acid (HVA) and 3,4-dihydroxyphenylacetic acid (DOPAC) reflected changes in tissue DA concentrations, indicating that release and metabolism of DA are similar to these characteristics observed in vivo. Western blot analysis of TH protein expression revealed large increases in VM TH after only 3 DIV, followed by a decline in levels through 17 DIV; levels of striatal TH, in contrast, increased through this period. Additionally, DAT and GAD 65/67 expression increased, in both the VM and striatum, over 17 DIV. By 17 DIV, many measures of DA function had decreased from those assessed at 10 DIV, thus providing an approximate limit to the effective duration of use of this co-culture model. Our results provide a much-needed description of the neurochemical changes that occur during the maturation of VM and striatum in organotypic co-cultures. Additionally, these results provide a foundation for future studies to assess toxic challenges of the developing nigrostriatal DA system, in vitro.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17196555      PMCID: PMC1850241          DOI: 10.1016/j.brainres.2006.11.053

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  37 in total

1.  Expression of GAD65 and GAD67 immunoreactivity in MPTP-treated monkeys with or without L-DOPA administration.

Authors:  Diane T Stephenson; Qiu Li; Carol Simmons; Mark A Connell; Martin D Meglasson; Kalpana Merchant; Marina E Emborg
Journal:  Neurobiol Dis       Date:  2005-11       Impact factor: 5.996

2.  Dopaminergic neurotoxins require excitotoxic stimulation in organotypic cultures.

Authors:  Geraldine J Kress; Ian J Reynolds
Journal:  Neurobiol Dis       Date:  2005-06-29       Impact factor: 5.996

3.  Dopaminergic modulation of striatal plateau depolarizations in corticostriatal organotypic cocultures.

Authors:  Kuei Y Tseng; Abigail Snyder-Keller; Patricio O'Donnell
Journal:  Psychopharmacology (Berl)       Date:  2006-06-07       Impact factor: 4.530

Review 4.  Cell therapy in Parkinson's disease.

Authors:  Olle Lindvall; Anders Björklund
Journal:  NeuroRx       Date:  2004-10

5.  Dopamine neurons in a simple GDNF-treated meso-striatal organotypic co-culture model.

Authors:  D S Schatz; W A Kaufmann; A Saria; C Humpel
Journal:  Exp Brain Res       Date:  1999-08       Impact factor: 1.972

6.  Neurotoxic and neurotrophic effects of chronic N-methyl-D-aspartate exposure upon mesencephalic dopaminergic neurons in organotypic culture.

Authors:  B G Dickie; C Holmes; S A Greenfield
Journal:  Neuroscience       Date:  1996-06       Impact factor: 3.590

7.  Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.

Authors:  Claudia M Testa; Todd B Sherer; J Timothy Greenamyre
Journal:  Brain Res Mol Brain Res       Date:  2005-01-06

8.  Dopaminergic innervation of forebrain by ventral mesencephalon in organotypic slice co-cultures: effects of GDNF.

Authors:  Juliann D Jaumotte; Michael J Zigmond
Journal:  Brain Res Mol Brain Res       Date:  2005-03-24

9.  Rat fetal ventral mesencephalon grown as solid tissue cultures: influence of culture time and BDNF treatment on dopamine neuron survival and function.

Authors:  G U Höglinger; J Sautter; M Meyer; C Spenger; R W Seiler; W H Oertel; H R Widmer
Journal:  Brain Res       Date:  1998-12-07       Impact factor: 3.252

10.  Re-examining the ontogeny of substantia nigra dopamine neurons.

Authors:  Monte A Gates; Eduardo M Torres; Anna White; Rosemary A Fricker-Gates; Stephen B Dunnett
Journal:  Eur J Neurosci       Date:  2006-03       Impact factor: 3.386

View more
  6 in total

Review 1.  Heterogeneity of dopamine release sites in health and degeneration.

Authors:  Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Neurobiol Dis       Date:  2019-11-05       Impact factor: 5.996

2.  Corticosterone enhances N-methyl-D-aspartate receptor signaling to promote isolated ventral tegmental area activity in a reconstituted mesolimbic dopamine pathway.

Authors:  Jennifer N Berry; Meredith A Saunders; Lynda J Sharrett-Field; Anna R Reynolds; Michael T Bardo; James R Pauly; Mark A Prendergast
Journal:  Brain Res Bull       Date:  2015-11-26       Impact factor: 4.077

3.  Effects of ciliary neurotrophic factor and leukemia inhibiting factor on oxytocin and vasopressin magnocellular neuron survival in rat and mouse hypothalamic organotypic cultures.

Authors:  Shirley B House; Congyu Li; Chunmei Yue; Harold Gainer
Journal:  J Neurosci Methods       Date:  2008-12-11       Impact factor: 2.390

4.  Graft outcomes influenced by co-expression of Pax7 in graft and host tissue.

Authors:  Meghan Thomas; Pam Tyers; Stanley E Lazic; Maeve A Caldwell; Roger A Barker; Lyn Beazley; Mel Ziman
Journal:  J Anat       Date:  2009-03       Impact factor: 2.610

5.  Polychlorinated biphenyl-induced oxidative stress in organotypic co-cultures: experimental dopamine depletion prevents reductions in GABA.

Authors:  Gregory D Lyng; Richard F Seegal
Journal:  Neurotoxicology       Date:  2007-12-28       Impact factor: 4.294

6.  Cocaine Causes Apoptotic Death in Rat Mesencephalon and Striatum Primary Cultures.

Authors:  Lucilia B Lepsch; Cleopatra S Planeta; Critoforo Scavone
Journal:  Biomed Res Int       Date:  2015-07-29       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.